- Home
- Publications
- Publication Search
- Publication Details
Title
Novel agents for the treatment of adenocarcinoma of the pancreas
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 9, Issue 10, Pages 1473-1485
Publisher
Informa UK Limited
Online
2009-10-15
DOI
10.1586/era.09.109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Results of a Phase I Trial of 12 Patients With Locally Advanced Pancreatic Carcinoma Combining Gefitinib, Paclitaxel, and 3-Dimensional Conformal Radiation
- (2009) Christine C. Olsen et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- HMGA2 Maintains Oncogenic RAS-Induced Epithelial-Mesenchymal Transition in Human Pancreatic Cancer Cells
- (2009) Sugiko Watanabe et al. AMERICAN JOURNAL OF PATHOLOGY
- Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study
- (2009) F Kullmann et al. BRITISH JOURNAL OF CANCER
- Design and Activity of a Murine and Humanized Anti-CEACAM6 Single-Chain Variable Fragment in the Treatment of Pancreatic Cancer
- (2009) C. J. Riley et al. CANCER RESEARCH
- Proteasome-Mediated Degradation and Functions of Hematopoietic Progenitor Kinase 1 in Pancreatic Cancer
- (2009) H. Wang et al. CANCER RESEARCH
- The Role of Tumor Cell-Derived Connective Tissue Growth Factor (CTGF/CCN2) in Pancreatic Tumor Growth
- (2009) K. L. Bennewith et al. CANCER RESEARCH
- Aflibercept (AVE0005): an alternative strategy for inhibiting tumour angiogenesis by vascular endothelial growth factors
- (2009) Quincy Siu-Chung Chu EXPERT OPINION ON BIOLOGICAL THERAPY
- S-1: a promising new oral fluoropyrimidine derivative
- (2009) Muhammad Wasif Saif et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer
- (2009) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- EFEMP1 Expression Promotes In vivo Tumor Growth in Human Pancreatic Adenocarcinoma
- (2009) H. Seeliger et al. MOLECULAR CANCER RESEARCH
- Vandetanib (ZD6474), a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases: Current Status and Future Directions
- (2009) A. Morabito et al. ONCOLOGIST
- Gemcitabine Plus Celecoxib in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma
- (2008) Tomislav Dragovich et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer
- (2008) Q Chang et al. BRITISH JOURNAL OF CANCER
- Targeted therapies for pancreatic cancer
- (2008) S. A. Danovi et al. BRITISH MEDICAL BULLETIN
- Pancreatic cancer: from molecular pathogenesis to targeted therapy
- (2008) Alexios Strimpakos et al. CANCER AND METASTASIS REVIEWS
- Pancreatic cancer: From molecular signature to target therapy
- (2008) R. Longo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Mechanisms of proteasome inhibitor action and resistance in cancer
- (2008) David J. McConkey et al. DRUG RESISTANCE UPDATES
- Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis
- (2008) Christian Moser et al. EUROPEAN JOURNAL OF CANCER
- Oral mTOR Inhibitor Everolimus in Patients With Gemcitabine-Refractory Metastatic Pancreatic Cancer
- (2008) Brian M. Wolpin et al. JOURNAL OF CLINICAL ONCOLOGY
- Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells
- (2008) Masao Fujiwara et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study
- (2008) Jean-Philippe Spano et al. LANCET
- Apoptotic pathways in pancreatic ductal adenocarcinoma
- (2008) Rainer Hamacher et al. Molecular Cancer
- New Therapeutic Directions for Advanced Pancreatic Cancer: Targeting the Epidermal Growth Factor and Vascular Endothelial Growth Factor Pathways
- (2008) H. Burris et al. ONCOLOGIST
- Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cells
- (2007) Amalia Azzariti et al. BIOCHEMICAL PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started